Resumen de The great prostate cancer debate.
The article discusses the debate regarding the benefits of the prostate-specific antigen (PSA) test, which is a routine blood test that is used to screen for prostate cancer. According to the U.S. Preventive Services Task Force, little of no long-term benefits are derived from the test and may do more harm than good. Topics include controversies about PSA tests resulting from flawed screening methods and treatments, side effects of prostate cancer treatment, such as impotence, and the growing body of evidence against PSA screening that suggests screening guidelines need to be updated. INSET: Disappointing Data.
